Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010 (2010), Article ID 105489, 10 pages
http://dx.doi.org/10.1155/2010/105489
Research Article

Leptin Inhibits the Proliferation of Vascular Smooth Muscle Cells Induced by Angiotensin II through Nitric Oxide-Dependent Mechanisms

1Metabolic Research Laboratory, University of Navarra, 31008 Pamplona, Spain
2CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Spain
3Division of Cardiovascular Sciences, Center for Applied Medical Research, University of Navarra, 31008 Pamplona, Spain
4Department of Endocrinology, Clínica Universidad de Navarra, 31008 Pamplona, Spain

Received 4 January 2010; Revised 31 March 2010; Accepted 31 March 2010

Academic Editor: Oreste Gualillo

Copyright © 2010 Amaia Rodríguez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. M. Touyz, “Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II,” Experimental Physiology, vol. 90, no. 4, pp. 449–455, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Fortuño, G. San José, M. U. Moreno, J. Díez, and G. Zalba, “Oxidative stress and vascular remodelling,” Experimental Physiology, vol. 90, no. 4, pp. 457–462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Friedman and J. L. Halaas, “Leptin and the regulation of body weight in mammals,” Nature, vol. 395, no. 6704, pp. 763–770, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Fortuño, A. Rodríguez, J. Gómez-Ambrosi, G. Frühbeck, and J. Díez, “Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases,” Journal of Physiology and Biochemistry, vol. 59, no. 1, pp. 51–60, 2003. View at Google Scholar · View at Scopus
  5. A. Rodríguez and G. Frühbeck, “Peptides involved in vascular homeostasis,” in Peptides in Energy Balance & Obesity, G. Frühbeck, Ed., pp. 229–261, CAB International, Oxford, UK, 2009. View at Google Scholar
  6. A. J. Marsh, M. A. P. Fontes, S. Killinger, D. B. Pawlak, J. W. Polson, and R. A. L. Dampney, “Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus,” Hypertension, vol. 42, no. 4, pp. 488–493, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Frühbeck, “Pivotal role of nitric oxide in the control of blood pressure after leptin administration,” Diabetes, vol. 48, no. 4, pp. 903–908, 1999. View at Google Scholar · View at Scopus
  8. G. Lembo, C. Vecchione, L. Fratta et al., “Leptin induces direct vasodilation through distinct endothelial mechanisms,” Diabetes, vol. 49, no. 2, pp. 293–297, 2000. View at Google Scholar · View at Scopus
  9. J. D. Knudson, U. D. Dincer, G. M. Dick et al., “Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction,” American Journal of Physiology, vol. 289, no. 3, pp. H1038–H1046, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Gálvez, J. de Castro, D. Herold et al., “Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive rats,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 6, pp. 1297–1302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Rodríguez, A. Fortuño, J. Gómez-Ambrosi, G. Zalba, J. Díez, and G. Frühbeck, “The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism,” Endocrinology, vol. 148, no. 1, pp. 324–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Villarreal, G. Reams, and R. H. Freeman, “Effects of renal denervation on the sodium excretory actions of leptin in hypertensive rats,” Kidney International, vol. 58, no. 3, pp. 989–994, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Villarreal, G. Reams, H. Samar, R. Spear, and R. H. Freeman, “Effects of chronic nitric oxide inhibition on the renal excretory response to leptin,” Obesity Research, vol. 12, no. 6, pp. 1006–1010, 2004. View at Google Scholar · View at Scopus
  14. L. E. Wold, D. P. Relling, J. Duan, F. L. Norby, and J. Ren, “Abrogated leptin-induced cardiac contractile response in ventricular myocytes under spontaneous hypertension role of JAK/STAT pathway,” Hypertension, vol. 39, no. 1, pp. 69–74, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Rodríguez, G. Frühbeck, J. Gómez-Ambrosi et al., “The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats,” Journal of Hypertension, vol. 24, no. 8, pp. 1589–1597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Agata, A. Masuda, M. Takada et al., “High plasma immunoreactive leptin level in essential hypertension,” American Journal of Hypertension, vol. 10, no. 10, part 1, pp. 1171–1174, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. J. H. Henriksen, J. J. Holst, S. Møller, U. B. Andersen, F. Bendtsen, and G. Jensen, “Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin,” Clinical Science, vol. 99, no. 6, pp. 527–534, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Oda, T. Taniguchi, and M. Yokoyama, “Leptin stimulates rat aortic smooth muscle cell proliferation and migration,” Kobe Journal of Medical Sciences, vol. 47, no. 3, pp. 141–150, 2001. View at Google Scholar · View at Scopus
  19. K. Schäfer, M. Halle, C. Goeschen et al., “Leptin promotes vascular remodeling and neointimal growth in mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 1, pp. 112–117, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Bohlen, J. Kratzsch, M. Mueller et al., “Leptin inhibits cell growth of human vascular smooth muscle cells,” Vascular Pharmacology, vol. 46, no. 1, pp. 67–71, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Conti, P. C. Morand, P. Levillain, and A. Lemonnier, “Improved fluorometric determination of malonaldehyde,” Clinical Chemistry, vol. 37, no. 7, pp. 1273–1275, 1991. View at Google Scholar · View at Scopus
  22. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  23. A. Rodríguez, V. Catalán, S. Becerril et al., “Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats,” Life Sciences, vol. 83, no. 15-16, pp. 540–549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. C. Chua Jr., W. K. Chung, X. S. Wu-Peng et al., “Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor,” Science, vol. 271, no. 5251, pp. 994–996, 1996. View at Google Scholar · View at Scopus
  25. B. A. da Silva, C. Bjørbæk, S. Uotani, and J. S. Flier, “Functional properties of leptin receptor isoforms containing the GlnPro extracellular domain mutation of the fatty rat,” Endocrinology, vol. 139, no. 9, pp. 3681–3690, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Otero, R. Lago, F. Lago, J. J. Reino, and O. Gualillo, “Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1,” Arthritis Research & Therapy, vol. 7, no. 3, pp. R581–591, 2005. View at Google Scholar · View at Scopus
  27. G. Mattace Raso, E. Esposito, A. Iacono et al., “Leptin induces nitric oxide synthase type II in C6 glioma cells: role for nuclear factor-?B in hormone effect,” Neuroscience Letters, vol. 396, no. 2, pp. 121–126, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Fernandez-Fernandez, A. C. Martini, V. M. Navarro et al., “Novel signals for the integration of energy balance and reproduction,” Molecular and Cellular Endocrinology, vol. 254-255, pp. 127–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Beltowski, G. Wojcicka, A. Jamroz-Wisniewska, and A. Marciniak, “Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome,” Life Science, vol. 85, no. 15-16, pp. 557–567, 2009. View at Google Scholar
  30. C. Vecchione, A. Maffei, S. Colella et al., “Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway,” Diabetes, vol. 51, no. 1, pp. 168–173, 2002. View at Google Scholar · View at Scopus
  31. B. Winters, Z. Mo, E. Brooks-Asplund et al., “Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice,” Journal of Applied Physiology, vol. 89, no. 6, pp. 2382–2390, 2000. View at Google Scholar · View at Scopus
  32. G. M. Raso, M. Pacilio, E. Esposito, A. Coppola, R. Di Carlo, and R. Meli, “Leptin potentiates IFN-γ-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A.1,” British Journal of Pharmacology, vol. 137, no. 6, pp. 799–804, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Mehebik, A. M. Jaubert, D. Sabourault, Y. Giudicelli, and C. Ribière, “Leptin-induced nitric oxide production in white adipocytes is mediated through PKA and MAP kinase activation,” American Journal of Physiology, vol. 289, no. 2, pp. C379–C387, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Vuolteenaho, A. Koskinen, M. Kukkonen et al., “Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage—mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production,” Mediators of Inflammation, vol. 2009, Article ID 345838, 10 pages, 2009. View at Publisher · View at Google Scholar
  35. M. W. Nickola, L. E. Wold, P. B. Colligan, G. J. Wang, W. K. Samson, and J. Ren, “Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO,” Hypertension, vol. 36, no. 4, pp. 501–505, 2000. View at Google Scholar · View at Scopus
  36. W. J. Arendshorst, C. Chatziantoniou, and F. H. Daniels, “Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension,” Kidney International, vol. 38, no. 30, pp. S92–S96, 1990. View at Google Scholar · View at Scopus
  37. R. M. Touyz, G. He, M. El Mabrouk, and E. L. Schiffrin, “p38 map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY,” Hypertension, vol. 37, no. 2, part 2, pp. 574–580, 2001. View at Google Scholar · View at Scopus
  38. M. Pravenec, V. Zídek, V. Landa et al., “Genetic analysis of “metabolic syndrome” in the spontaneously hypertensive rat,” Physiological Research, vol. 53, no. 1, pp. S15–S22, 2004. View at Google Scholar · View at Scopus